Hydroflumethiazide Generic, Saluron
Indapamide Generic, Lozol
Mannitol Generic, Osmitrol
Methazolamide (for ocular Generic, Neptazane conditions)
Methyclothiazide Generic, Aquatensen, Enduron
Metolazone Generic, Mykrox, Zaroxolyn (Note: Bioavailability of Mykrox is greater than that of Zaroxolyn)
Polythiazide Renese, combination drugs *
Spironolactone Generic, Aldactone, combination drugs*
Torsemide Generic, Demadex
Trichlormethiazide Generic, Diurese, Naqua, others
Eplerenone Inspra Furosemide Generic, Lasix, others Tolvaptan Samsca Triamterene Dyrenium *Combination drugs: see Table 15–6.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981.
Bakris GL et al: Effect of finerenone on albuminuria in patients with diabetic nephropathy. JAMA 2015;314:884.
Berl T et al: Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 2010;21:705.
Bokrantz T et al: Thiazide diuretics and fracture-risk among hypertensive patients. Results from the Swedish primary care cardiovascular database (SPCCD). J Hypertens 2015;33:e94.
Brater DC: Mechanism of action of diuretics. UpToDate, 2013. http://www. uptodate.com.
Brenner BM (editor): Brenner & Rector’s The Kidney, 8th ed. Saunders, 2008.
Cefalu WT et al: Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATASU): 52 week results from a randomized, double-blind, phase 3 non-inferiority trial. Lancet 2014;382:941.
Cooper BE: Diuresis in renal failure: Treat the patient, not the urine output. Crit Care Med 2009;37:761.
Costello-Boerrigter LC, Boerrigter G, Burnett JC Jr: Revisiting salt and water retention: New diuretics, aquaretics, and natriuretics. Med Clin North Am 2003;87:475.
Ernst ME, Moser M: Use of diuretics in patients with hypertension. N Engl J Med 2009;361:2153.
Forssmann W-G, Meyer M, Forsmann K: The renal urodilatin system: Clinical implications. Cardiovasc Res 2001;51(3):450.
Ginés P, Schrier RW: Renal failure in cirrhosis. N Engl J Med 2009;361:1279.
Hao C-M, Breyer MD: Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol 2008;70:357.
Hays RM: Vasopressin antagonists: Progress and promise. N Engl J Med 2006; 355:146.
Hill JA, Yancy CW, Abraham WT: Beyond diuretics: Management of volume overload in acute heart failure syndromes. Am J Med 2006;119:S37.